Study of Anti-Oxidant in Multiple Sclerosis
IRB# 1305, Principal Investigator: Vijayshree Yadav, M.D.
The Multiple Sclerosis (MS) Center of Oregon at Oregon Health & Science University is looking for people with a confirmed diagnosis of MS to participate in a research study that will require several blood draws and saliva collection. The purpose of the study is to determine the bioavailability of an oral antioxidant, alpha lipoic acid (ALA) in MS patients.
If you are between 18 and 70 years of age, and have a confirmed diagnosis of MS, you may be eligible to participate in this study.
You will not be eligible to participate in this study if you are pregnant or breast feeding, have experienced a relapse in last 30 days, have taken ALA in last 2 weeks, or have a serious health condition other than MS (e.g. anemia, uncontrolled diabetes, cancer, liver disease, lung disease, congestive heart failure).
This study requires two visits to OHSU. The research study will pay for all costs associated with the participation in this study. You will be eligible to receive $50 as a token compensation at the completion of the study. You will be responsible for any expenses that have to do with other aspects of your participation, such as childcare or transportation.
If you meet the eligibility requirements described above and are interested in participating in this study, please call Dr. Vijayshree Yadav at (503) 494-7241.